Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- New NJACTS Publication
- Rutgers Researchers Help Redefine Core Microbiome, Opening New Chapter in Precision Health.
- Interested in Accessing Clinical Data?
- Rutgers Health has big plans to spend $47.5M on new ideas at gleaming new Helix tower.
- NJIT Launches AI-Powered Solar Eruption Center with $5M NASA Grant.
Categories
- Community (2,071)
- Covid (979)
- CTO Events (5)
- News (2,632)
- Pilots (20)